Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CMND

Clearmind Medicine (CMND)

Clearmind Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:CSE:CMND
DateTimeSourceHeadlineSymbolCompany
26/01/202300:48InvestorsHub NewsWireHebrew University' Yissum and Israeli Biotech Clearmind Medicine's Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023CSE:CMNDClearmind Medicine Inc
11/01/202301:16InvestorsHub NewsWireIsrael-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical TrialCSE:CMNDClearmind Medicine Inc
06/01/202301:05InvestorsHub NewsWireIsrael-Based Clearmind Medicine Shows Efficacy of Psychedelic-Derived Obesity Treatment in Pre-Clinical TrialCSE:CMNDClearmind Medicine Inc
22/12/202205:49InvestorsHub NewsWireIsrael-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol SubstituteCSE:CMNDClearmind Medicine Inc
24/11/202201:50InvestorsHub NewsWireClearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical TrialCSE:CMNDClearmind Medicine Inc
24/05/202222:36InvestorsHub NewsWireSciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination TreatmentCSE:CMNDClearmind Medicine Inc
 Showing the most relevant articles for your search:CSE:CMND